MedPath

Protein Absorption in Adults

Not yet recruiting
Conditions
Adult healthy volunteers, mainly staff of St. John’s Medical College and Research Institute, and their known contacts, in the age range of 18 to 35 years
Registration Number
CTRI/2021/06/034006
Lead Sponsor
Queen Mary University of London Global Challenge Research Fund
Brief Summary

Environmental Enteropathy (EE) is a global disorder which contributes to poor child growth, micronutrient deficiencies, and impaired responses to oral vaccines. There is evidence that EE is associated with malabsorption of zinc, but the effects on other intestinal functions are unknown. The principal function of the intestine is to digest and absorb nutrients from the luminal stream, and several biochemical processes are essential to this dominant function. These processes include digestion of proteins into amino acids and dipeptides, digestion of complex carbohydrates into monosaccharides, emulsification and digestion of lipids. Nutrients, including these macronutrients together with micronutrients such as elements and vitamins, are absorbed by epithelial cells using a very complex array of several hundred transporters. A considerable amount of research was carried out on nutrient digestion and absorption in the 1960s and 1970s, but much less has been done recently. Recent elucidation of the importance of EE in global health and nutrition has highlighted the lack of information on digestion and absorption in the world literature, and there is almost no information on the impairments of digestion and absorption related to EE in adults and children in low and middle income countries.

A clinical study of the 13C sucrose breath test (13C-SBT) and the 13C mixed chain triglyceride test (13C-MCTT), was conducted by Paul Kelly and colleagues (collaborating team). The results of the SBT show useful correlation between 13CO2 in breath and three measures of intestinal dysfunction: villus height and surface area, mucosal sucrose-isomaltase expression by immunostaining, and sucrose activity measured ex vivo in biopsies. However, this test only measures mucosal disaccharidase activity. We now want to go on and find tests for other aspects of mucosal digestive/absorptive function.

The significance of this study is that impairments of digestive and absorptive function can be overcome, by using enzymatic supplements, by using specially modified feeds, and/or by providing additional specific nutrients to overcome absorptive defects. While we are developing these tests in adults, the longer term objective is to adapt them for use in children with growth faltering, and to define nutritional modifications which these children may need.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Normal BMI between18.5 to 25 Kg/m².

Exclusion Criteria

History of smoking or taking other leisure drugs · Consumption of alcohol in the previous 24 hours · History of antibiotic usage 4 weeks prior to the study · On iron supplementation therapy (3 months) · On medication such as NSAID’s, proton pump inhibitors or H2 blockers 2 days prior to and on the study day · Participation in any nutritional study in the last 6 months · History of food allergy, specifically to milk · Diagnosed with chronic medical or surgical illness.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine associations between uptake of C6, 15N allo-isoleucine or uptake of dipeptide Gly-Sar with lactulose-rhamnose ratio and pro inflammatory markers in stool and plasma.Outcome will be assessed only on the experiment day, so only one time point.
Secondary Outcome Measures
NameTimeMethod
Not applicableNot applicable

Trial Locations

Locations (1)

St. Johns Research Institute

🇮🇳

Bangalore, KARNATAKA, India

St. Johns Research Institute
🇮🇳Bangalore, KARNATAKA, India
Dr Nirupama Shivakumar
Principal investigator
9900070008
nirupama.s@sjri.res.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.